5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.70▼ | 4.65▲ | 4.65▲ | 4.64▼ | 5.19▼ |
MA10 | 4.68▼ | 4.66▲ | 4.66▲ | 4.76▼ | 9.37▼ |
MA20 | 4.79▼ | 4.82▼ | 4.81▼ | 5.22▼ | 33.83▼ |
MA50 | 4.90▼ | 4.89▼ | 4.87▼ | 10.91▼ | 32.77▼ |
MA100 | 4.89▼ | 5.50▼ | 5.75▼ | 36.84▼ | 24.90▼ |
MA200 | 5.22▼ | 6.46▼ | 9.01▼ | 37.50▼ | 66.13▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.013▼ | -0.003▼ | 0.587▲ | -4.155▼ |
RSI | 40.015▼ | 42.279▼ | 43.307▼ | 27.245▼ | 37.343▼ |
STOCH | 51.111 | 22.370 | 22.370 | 23.744 | 0.746▼ |
WILL %R | -86.076▼ | -88.889▼ | -88.889▼ | -93.015▼ | -99.867▼ |
CCI | -41.516 | -46.257 | -46.265 | -156.510▼ | -74.179 |
Friday, June 13, 2025 05:27 AM
SEATTLE, WA / ACCESS Newswire / June 13, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its pro ...
|
Friday, June 13, 2025 05:05 AM
SEATTLE, WA / ACCESS Newswire / June 13, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its ...
|
Monday, June 09, 2025 12:59 PM
SEATTLE, WA / ACCESS Newswire / May 22, 2025 /Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 4.71 | 4.75 | 4.30 | 4.39 | 148,127 |
12/06/25 | 4.61 | 4.78 | 4.51 | 4.78 | 24,750 |
11/06/25 | 4.71 | 4.8923 | 4.59 | 4.65 | 77,591 |
10/06/25 | 4.61 | 4.70 | 4.61 | 4.70 | 17,843 |
09/06/25 | 5.09 | 5.09 | 4.61 | 4.68 | 79,651 |
06/06/25 | 4.80 | 5.10 | 4.80 | 4.95 | 59,866 |
05/06/25 | 4.98 | 5.18 | 4.78 | 4.78 | 58,449 |
04/06/25 | 4.97 | 5.1287 | 4.76 | 4.96 | 71,353 |
03/06/25 | 4.75 | 5.11 | 4.75 | 4.975 | 111,540 |
02/06/25 | 4.78 | 5.5885 | 4.6101 | 4.77 | 384,594 |
|
|
||||
|
|
||||
|
|